Jones Financial Companies’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$113M Buy
4,638,683
+117,340
+3% +$3.07M 0.05% 224
2026
Q1
$122M Buy
4,521,343
+938,114
+26% +$25M 0.06% 169
2025
Q4
$89.2M Buy
3,583,229
+268,117
+8% +$6.76M 0.05% 112
2025
Q3
$78.8M Buy
3,315,112
+297,458
+10% +$7.34M 0.05% 106
2025
Q2
$73M Buy
3,017,654
+501,443
+20% +$11.7M 0.06% 104
2025
Q1
$63.4M Buy
2,516,211
+690,259
+38% +$18.1M 0.06% 92
2024
Q4
$48.4M Buy
1,825,952
+485,895
+36% +$13.2M 0.05% 93
2024
Q3
$39M Buy
1,340,057
+627,680
+88% +$18.3M 0.04% 89
2024
Q2
$19.9M Buy
712,377
+268,623
+61% +$7.4M 0.02% 100
2024
Q1
$12.3M Buy
443,754
+95,130
+27% +$2.64M 0.02% 101
2023
Q4
$10M Sell
348,624
-30,151
-8% -$911K 0.02% 103
2023
Q3
$12.6M Buy
378,775
+6,772
+2% +$239K 0.02% 81
2023
Q2
$13.6M Buy
372,003
+545
+0.1% +$21.2K 0.02% 80
2023
Q1
$15.2M Buy
371,458
+8,540
+2% +$369K 0.02% 75
2022
Q4
$18.6M Buy
362,918
+3,557
+1% +$171K 0.03% 71
2022
Q3
$15.7M Sell
359,361
-6,873
-2% -$334K 0.03% 63
2022
Q2
$19.2M Sell
366,234
-6,496
-2% -$331K 0.03% 58
2022
Q1
$19.3M Sell
372,730
-12,401
-3% -$643K 0.03% 64
2021
Q4
$22.7M Buy
385,131
+17,871
+5% +$885K 0.03% 62
2021
Q3
$15.8M Sell
367,260
-504
-0.1% -$22.3K 0.02% 73
2021
Q2
$14.4M Buy
367,764
+9,466
+3% +$368K 0.02% 77
2021
Q1
$13M Buy
358,298
+7,005
+2% +$249K 0.02% 82
2020
Q4
$12.9M Sell
351,293
-5,571
-2% -$204K 0.02% 81
2020
Q3
$12.4M Buy
356,864
+12,852
+4% +$451K 0.03% 73
2020
Q2
$10.7M Sell
344,012
-20,253
-6% -$688K 0.02% 77
2020
Q1
$11.3M Buy
364,265
+1,842
+0.5% +$62.8K 0.03% 68
2019
Q4
$13.5M Buy
362,423
+1,612
+0.4% +$57.4K 0.03% 69
2019
Q3
$12.3M Buy
360,811
+3,740
+1% +$136K 0.03% 70
2019
Q2
$14.7M Buy
357,071
+11,158
+3% +$443K 0.03% 57
2019
Q1
$13.9M Sell
345,913
-1,776
-0.5% -$71.1K 0.03% 59
2018
Q4
$14.4M Sell
347,689
-39,795
-10% -$1.65M 0.04% 52
2018
Q3
$16.2M Sell
387,484
-3,200
-0.8% -$123K 0.04% 49
2018
Q2
$13.4M Sell
390,684
-5,287
-1% -$181K 0.03% 56
2018
Q1
$13.3M Sell
395,971
-8,721
-2% -$300K 0.03% 51
2017
Q4
$13.9M Buy
404,692
+2,149
+0.5% +$73.3K 0.03% 51
2017
Q3
$13.6M Sell
402,543
-12,193
-3% -$392K 0.04% 51
2017
Q2
$13.2M Sell
414,736
-21,096
-5% -$665K 0.04% 51
2017
Q1
$14.1M Sell
435,832
-6,063
-1% -$191K 0.05% 46
2016
Q4
$13.6M Buy
441,895
+835
+0.2% +$25.5K 0.05% 46
2016
Q3
$14.2M Sell
441,060
-14,467
-3% -$484K 0.06% 45
2016
Q2
$15.2M Sell
455,527
-14,694
-3% -$469K 0.07% 37
2016
Q1
$13.2M Buy
470,221
+1,917
+0.4% +$54.8K 0.08% 31
2015
Q4
$14.3M Buy
468,304
+1,640
+0.4% +$51.6K 0.09% 30
2015
Q3
$13.9M Buy
466,664
+23,757
+5% +$762K 0.09% 28
2015
Q2
$14.1M Sell
442,907
-7,971
-2% -$260K 0.09% 28
2015
Q1
$14.9M Sell
450,878
-35,304
-7% -$1.12M 0.1% 26
2014
Q4
$14.4M Sell
486,182
-3,632
-0.7% -$104K 0.1% 29
2014
Q3
$13.7M Buy
489,814
+17,208
+4% +$483K 0.1% 27
2014
Q2
$13.3M Buy
472,606
+48,343
+11% +$1.38M 0.1% 27
2014
Q1
$12.9M Sell
424,263
-17,512
-4% -$522K 0.11% 26
2013
Q4
$12.8M Buy
441,775
+13,452
+3% +$392K 0.11% 26
2013
Q3
$11.7M Buy
428,323
+12,281
+3% +$334K 0.11% 26
2013
Q2
$11.1M Buy
+416,042
New +$11.5M 0.12% 26

Other funds holding PFE

Jones Financial Companies's PFE Position: Q2 2026 in Review

Jones Financial Companies increased its Pfizer (PFE) stake by 2.6% in Q2 2026, buying an estimated $3.07M and bringing the position to 4,638,683 shares worth $113M. The position accounts for 0.05% of the portfolio, ranked #224.

Jones Financial Companies first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $122M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Jones Financial Companies held 4,638,683 shares of Pfizer worth $113M as of Q2 2026.
  • Jones Financial Companies bought 117,340 Pfizer shares in Q2 2026, an estimated $3.07M.
  • Pfizer made up 0.05% of Jones Financial Companies's portfolio in Q2 2026, its #224 holding.
  • Jones Financial Companies first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Jones Financial Companies's Pfizer position peaked at $122M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.